SPM-011
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPM-011, covering 2025-04-09 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Using CICS-1 and SPM-011 and [18F]FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA [Phase 1, Phase 2]